All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Texas A&M study identifies NR4A1 receptor activation as key mechanism behind coffee's health benefits

By

Camryn Haines

28d ago· 5 min readenNews

Summary

New research from Texas A&M University reveals that compounds in coffee may activate the NR4A1 receptor in the body, a protein linked to aging, stress response, and disease. This discovery helps explain the long-observed association between coffee consumption and longer life, as well as lower risk of chronic diseases. The study provides a biological mechanism for coffee's widespread health effects beyond its well-known wakefulness properties.

Key quotes

· 2 pulled
For decades, research has linked coffee consumption to longer life and lower risk of chronic disease—but exactly how those benefits occur has remained unclear.
Now, new research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) suggests that compounds in coffee may work, in part, by activating a receptor in the body known as NR4A1—a protein increasingly recognized for its role in aging, stress response and disease.
Snippet from the RSS feed
For decades, research has linked coffee consumption to longer life and lower risk of chronic disease—but exactly how those benefits occur has remained unclear. Now, new research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VM

You might also wanna read

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·1h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·1h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·1h ago

Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds

An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks

bit.ly·4h ago

Woman develops whiplike rash on back after eating shiitake mushrooms

A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas

livescience.com·5h ago

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins

pasadenastarnews.com·8h ago